Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 3 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Evonik Oxeno GmbH & Co. Kg has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners across 3 distinct art units, creating examiner and art-unit distribution with some assignment concentration.
WITHERSPOON, SIKARL A is the busiest examiner, with 2 pending matters. Those matters should receive coordinated attention, while the remaining work should be handled in light of its separate examination assignments.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WITHERSPOON, SIKARL A | 2 | 86.3% | -20.1% |
| HINES, LATOSHA D | 1 | 51.4% | +21.6% |
| BONAPARTE, AMY C | 1 | 79.1% | +23.5% |
| LING, DORIS | 1 | 25.0% | +27.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18638013 | Process for alkoxycarbonylation of olefins using synthesis gas | WITHERSPOON, SIKARL A | — |
| 18410227 | Mixture of two constitutionally isomeric bisphosphites | WITHERSPOON, SIKARL A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18631125 | CATALYST AND PROCESS FOR HYDROGENATION OF OLEFINS | HINES, LATOSHA D | — |
| 18476766 | TETRAISOPENTYL ESTERS OF BUTANETETRACARBOXYLIC ACID HAVING A HIGH PROPORTION OF 3-METHYLBUTYL RADICALS | LING, DORIS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18631125 | CATALYST AND PROCESS FOR HYDROGENATION OF OLEFINS | HINES, LATOSHA D | — |
| 18541611 | Diphosphites with a dicyclohexylphosphino radical | BONAPARTE, AMY C | — |
| 18476766 | TETRAISOPENTYL ESTERS OF BUTANETETRACARBOXYLIC ACID HAVING A HIGH PROPORTION OF 3-METHYLBUTYL RADICALS | LING, DORIS | — |
| Art Unit | Apps |
|---|---|
| 1692 | 3 |
| 1771 | 1 |
| 1764 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18638013 | Process for alkoxycarbonylation of olefins using synthesis gas | WITHERSPOON, SIKARL A | 1692 | §103 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18631125 | CATALYST AND PROCESS FOR HYDROGENATION OF OLEFINS | HINES, LATOSHA D | 1771 | §102§103 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18410227 | Mixture of two constitutionally isomeric bisphosphites | WITHERSPOON, SIKARL A | 1692 | §103 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18541611 | Diphosphites with a dicyclohexylphosphino radical | BONAPARTE, AMY C | 1692 | §112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18476766 | TETRAISOPENTYL ESTERS OF BUTANETETRACARBOXYLIC ACID HAVING A HIGH PROPORTION OF 3-METHYLBUTYL RADICALS | LING, DORIS | 1764 | §102§103 | Final Rejection | — | Pending | Sep 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEvonik Oxeno GmbH & Co. Kg has 5 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Sikarl A Witherspoon has the most, with 2 of Evonik Oxeno GmbH & Co. Kg's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
